Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.

计划入组 48 人 · 首次发布于 2008 年 9 月 19 日

Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children

计划入组 60 人 · 首次发布于 2009 年 11 月 16 日

A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

计划入组 991 人 · 首次发布于 2024 年 4 月 24 日

pandemic influenza vaccine

Pandemic Preparedness (PostEra)

H5N1 influenza pandemic vaccine

Sernova Corp

Canada

Invivyd

United States

CEL-SCI

United States

I-SPY COVID Trial: Adaptive Platform Design Accelerates COVID-19 Therapeutic Discovery

Global Clinical Trial Landscape Adapts to Post-Pandemic Research Challenges

Adolescent Drug Overdose Deaths Show First Decline Since Pandemic Onset